Hormonas y lipoproteínas de alta densidad.

Joint effects of C-reactive protein and other risk factors on acute coronary events.

American heart journal·2001

Infections, inflammation, and the risk of coronary heart disease.

Circulation·2000

Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.

Circulation·1999

Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.

Archives of internal medicine·1998

Antibodies to prothrombin crossreact with plasminogen in patients developing myocardial infarction.

British journal of haematology·1998

QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population.

Heart (British Cardiac Society)·1997

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Longstanding Transcriptional Activation of APOA1 and PON1 in Human Hepatocytes by CRISPR/dCas9 Technology: Transcriptomic Profile and Crosstalk with Endothelial Cells.

International journal of molecular sciences·2026

Air purifiers in classrooms for infection control: a pilot study including a randomized multiple crossover trial to evaluate effectiveness in reducing particulate matter.

Trials·2026

The Association Between High-Efficiency Particulate Air (HEPA) Filter Usage and Asthma Outcomes in a High Atmospheric Dust Environment: A Cross-Sectional Analysis.

Cureus·2026

CRISPR-PITA: An Imaging-Based CRISPR/dCas9 Assay to Determine Recruitment Directionality of Nuclear Proteins.

Bio-protocol·2026

Effects of pole position and grip height on upper-body kinetics and throwing performance in paralympic seated shot put.

Frontiers in sports and active living·2026

Something old, something new? Herpesvirus genome packaging examined in light of lessons from the tailed bacteriophages.

Journal of virology·2026

Videos de Experimentos Relacionados

Hormonas y lipoproteínas de alta densidad.

Videos de Conceptos Relacionados

Joint effects of C-reactive protein and other risk factors on acute coronary events.

Infections, inflammation, and the risk of coronary heart disease.

Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.

Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.

Antibodies to prothrombin crossreact with plasminogen in patients developing myocardial infarction.

QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Longstanding Transcriptional Activation of APOA1 and PON1 in Human Hepatocytes by CRISPR/dCas9 Technology: Transcriptomic Profile and Crosstalk with Endothelial Cells.

Air purifiers in classrooms for infection control: a pilot study including a randomized multiple crossover trial to evaluate effectiveness in reducing particulate matter.

The Association Between High-Efficiency Particulate Air (HEPA) Filter Usage and Asthma Outcomes in a High Atmospheric Dust Environment: A Cross-Sectional Analysis.

CRISPR-PITA: An Imaging-Based CRISPR/dCas9 Assay to Determine Recruitment Directionality of Nuclear Proteins.

Effects of pole position and grip height on upper-body kinetics and throwing performance in paralympic seated shot put.

Something old, something new? Herpesvirus genome packaging examined in light of lessons from the tailed bacteriophages.

Videos de Experimentos Relacionados

Hormonas y lipoproteínas de alta densidad.

Videos de Conceptos Relacionados

Artículos Relacionados